# An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder

> **NCT07693608** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Obesity
- Methamphetamine Use Disorder
- Cocaine Use Disorder
- Stimulant Use Disorders

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07693608
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-08-19
- **Primary completion:** 2030-02-01
- **Final completion:** 2030-03-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07693608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07693608, "An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07693608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*